A Myxococcus xanthus rppA-mmrA double mutant exhibits reduced uptake of amino acids and tolerance of some antimicrobials

Add time:09/01/2019    Source:sciencedirect.com

Myxococcus xanthus RppA and MmrA are homologous to methyl-accepting chemotaxis proteins (MCPs) and to multidrug transporters, respectively. We reported previously that rppA-mmrA double mutant exhibited reduced colony expansion, agglutination, and polysaccharide levels. We have demonstrated here that the rppA-mmrA mutant also exhibited reduced amino acid uptake. Furthermore, the double mutant appeared to be more susceptible to some antimicrobial agents, such as streptomycin, ethidium bromide and norfloxacin, than the wild-type. These phenotypes were not shown in the rppA or mmrA single mutant. These results indicate that M. xanthus RppA and MmrA are also involved in the uptake of amino acids and efflux of some antimicrobial agents.

We also recommend Trading Suppliers and Manufacturers of protein U, Myxococcus (cas 138546-72-2). Pls Click Website Link as below: cas 138546-72-2 suppliers

Prev:ArticleDual Biochemical Oscillators May Control Cellular Reversals in Myxococcus xanthus
Next:Research letterTranscriptional regulation of genes required for antibiotic TA synthesis in Myxococcus xanthus)